Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2022;12(4): 763-771. doi: 10.34172/apb.2022.078
PMID: 36415627        PMCID: PMC9675932

Mini Review

Nanostructured Lipid Carriers for Nose to Brain Delivery TargetingCNS: Diversified Role of Liquid Lipids for Synergistic Action

Avinash Ramrao Tekade 1 * ORCID, Pradeep Sadanand Mittha 1, Charushila Sopan Pisal 1

Cited by CrossRef: 3

1- Das M, Sarma A, Baruah H, Basak D. Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway. RSC Pharm. 2024;1(5):904 [Crossref]
2- Shahraki O, Nabavinia M, Tiba A, Daneshmand S. Piperine and Lavender Oil Enriched Nanostructured Lipid Carriers to Inhibit Staphylococcus aureus Biofilm. Jundishapur J Nat Pharm Prod. 2025;20(1) [Crossref]
3- Zheng B, Liu D, Qin X, Zhang D, Zhang P. Mucoadhesive-to-Mucopenetrating Nanoparticles for Mucosal Drug Delivery: A Mini Review. IJN. 2025;Volume 20:2241 [Crossref]
4- Shah S, Patel A, Prajapati B, Alexander A, Pandya V, Trivedi N, Pandey P, Patel S, Patel R. Multifaceted nanolipidic carriers: a modish stratagem accentuating nose-to-brain drug delivery. J Nanopart Res. 2023;25(7) [Crossref]
5- Padti A, Bhavi S, Thokchom B, Singh S, Bhat S, Harini B, Sillanpää M, Yarajarla R. Nanoparticle Interactions with the Blood Brain Barrier: Insights from Drosophila and Implications for Human Astrocyte Targeted Therapies. Neurochem Res. 2025;50(1) [Crossref]
6- Sartaj A, Nabi B, Iqubal A, Aggarwal N, Haider K, Baboota S, Ali J. Development and Characterization of Oral Efavirenz-Loaded Nanostructured Lipid Carriers and Their Optimization with Box–Behnken Design Approach for the Neurological Disorder. ASSAY and Drug Development Technologies. 2025;23(2):84 [Crossref]
7- Chaudhri N, Rastogi V, Verma A. A Review on Lipid-based Nanoformulations for Targeting Brain through Non-invasive Nasal Route. PNT. 2025;13(1):143 [Crossref]